Ab NCISM syllabus ke mutabiq poore notes tayaar hain. Pesh-e-khidmat hain:
AMRAZ-E-DAM (خون کے امراض)
Blood Disorders - NCISM BUMS Syllabus
Modern Medicine + Unani Notes
NCISM Chapter 24 - Amraz-e-Dam Topics:
- Soo-ul-Qiniya / Faqr-ud-Dam (Anaemia)
- Sartan-ud-Dam (Leukaemia)
- Thalassemia
- Nazf-ud-Dam Mizaji (Haemophilia)
- Qillat-e-Sufehiyat-ud-Dam (Thrombocytopenia)
- Sickle Cell Disease
- Lymphoma
1. ANEMIA - SOO-UL-QINIYA / FAQR-UD-DAM
MODERN MEDICINE
Definition
WHO Definition:
- Male: Hb < 13 g/dL
- Female (non-pregnant): Hb < 12 g/dL
- Pregnant female: Hb < 11 g/dL
- Children 6-59 months: Hb < 11 g/dL
Classification by MCV (Most Important for Exams)
| Type | MCV | Causes |
|---|
| Microcytic Hypochromic | <80 fL, MCHC <30% | Iron deficiency, Thalassemia, Sideroblastic, Lead poisoning |
| Normocytic Normochromic | 80-100 fL | Aplastic anemia, Hemolytic, Acute blood loss, CKD, ACD |
| Macrocytic | >100 fL | B12 deficiency, Folate deficiency, Hypothyroidism, Liver disease |
A - Iron Deficiency Anemia (Most Common)
Pathophysiology: Blood loss (most common in adults) → depleted iron stores → reduced hemoglobin synthesis → microcytic hypochromic anemia
Causes:
- Women: Menstrual blood loss (most common)
- Men/Post-menopausal women: GI bleeding (investigate for occult blood)
- Children: Dietary deficiency
Lab Findings:
| Test | Iron Deficiency |
|---|
| Serum Iron | ↓ (<30 mcg/dL) |
| TIBC | ↑ (increased) |
| Transferrin saturation | ↓ (<15%) |
| Serum Ferritin | ↓ <20 mcg/L (most sensitive early test) |
| MCV | ↓ (<80 fL) |
| RDW | ↑ (anisocytosis) |
| Zinc Protoporphyrin (ZPP) | ↑ |
| Blood film | Hypochromic + microcytic + pencil cells (elliptocytes) |
Treatment:
- Oral Iron (preferred): Ferrous sulfate 325 mg (65 mg elemental iron) - 2-4 tabs/day
- 200-400 mg elemental iron/day = optimal
- Continue 3-6 months after correction to replenish stores
- Parenteral Iron: For malabsorption, CKD on dialysis, intolerance to oral iron
- Treat underlying cause (stop bleeding source)
B - Megaloblastic Anemia (B12 & Folate Deficiency)
| Feature | B12 Deficiency | Folate Deficiency |
|---|
| MCV | >100 fL | >100 fL |
| Serum level | B12 <100 pmol/L | Folate <4 ng/mL |
| Neurological signs | Yes (subacute combined degeneration) | No |
| Homocysteine | ↑ | ↑ |
| Methylmalonic acid | ↑ | Normal |
| Causes | Pernicious anemia, veganism, gastric surgery | Pregnancy, malnutrition, alcohol |
| Treatment | IM Cyanocobalamin | Folic acid 5 mg/day |
Blood film: Hypersegmented neutrophils (5+ lobes) + macro-ovalocytes
C - Aplastic Anemia
Definition: Pancytopenia (↓ RBC + ↓ WBC + ↓ Platelets) due to failure of bone marrow stem cells
Causes: Idiopathic (50%), drugs (chloramphenicol, NSAIDs), radiation, viruses (EBV, Hepatitis), autoimmune
Diagnosis: Bone marrow biopsy - hypocellular marrow with fat replacement
Treatment:
- Allogeneic Bone Marrow Transplant (curative, <40 years)
- Immunosuppression: Anti-thymocyte globulin (ATG) + Cyclosporine
- Supportive: Transfusions, G-CSF, Erythropoietin
D - Hemolytic Anemia
Features: ↑ Bilirubin (unconjugated), ↑ LDH, ↓ Haptoglobin, ↑ Reticulocytes, Splenomegaly
| Type | Examples |
|---|
| Intrinsic (Corpuscular) | Sickle cell, Thalassemia, G6PD deficiency, Hereditary spherocytosis |
| Extrinsic (Extracorpuscular) | Autoimmune (AIHA), Drug-induced, Mechanical (prosthetic valves), Malaria |
Coombs Test:
- Positive = Immune/autoimmune hemolysis (AIHA)
- Negative = Non-immune hemolysis
UNANI - SOO-UL-QINIYA / FAQR-UD-DAM
Unani Definition (Ibn Sina):
"Soo-ul-Qiniya woh halat hai jis mein khoon ki miqdar ya khasoosiyat mein nuqs ho jaata hai"
- Ibn Sina ne pehli baar Soo-ul-Qiniya ka zikr kiya - ise Istisqa (anasarca/dropsy) ka muqaddam (precursor) kaha
Synonyms: Faqr-ud-Dam, Qillat-ud-Dam, Fasa-ud-Dam, Khizra
Unani Pathogenesis:
- Zo'f-e-Kabid (Liver weakness) - kabd khoon banaata hai, jab liver kamzor ho to khoon ki ifrazish kam hoti hai
- Zo'f-e-Quwwat-e-Ghaziya - nutri-absorptive weakness
- Soo-e-Mizaj-e-Kabid - liver temperament imbalance
- Imtilaa - congestion blocking normal blood formation
Unani Treatment - Ilaj
1. Ilaj-bil-Ghiza (Dietotherapy):
- Ghiza-e-Lateef (easily digestible nutritious food)
- Kaseer-ul-Taghziya (highly nutritious diet)
- Gosht ka yakhni, anda, daliya, Anar (pomegranate), Maweez (raisins), Anjeer (figs), Palak, Methi
2. Ilaj-bil-Tadbeer (Regimental Therapy):
- Riyazat (appropriate exercise) - blood circulation improve karna
- Dalk (massage) - to stimulate blood flow
3. Ilaj-bil-Dawa - Single Drugs (Mufrad Adwiya):
| Drug (Unani) | Scientific Name | Action |
|---|
| Zafran (زعفران) | Crocus sativus | Mufarreh, blood tonic |
| Maweez (مویز) | Vitis vinifera (raisins) | Iron-rich, hematinic |
| Balchhar (بالچر) | Nardostachys jatamansi | Liver tonic, hematinic |
| Khabsul Hadeed (خبث الحدید) | Ferric oxide (iron rust) | Iron supplement |
| Rewand Chini | Rheum emodi | Liver tonic |
| Arqe Gulab | Rosa damascena | Blood purifier |
| Asgand | Withania somnifera | Blood tonic, immune booster |
4. Murakkab Adwiya (Compound Formulations):
| Formula | Action |
|---|
| Sharbat-e-Faulad (شربت فولاد) | Iron supplement - hematinic |
| Sharbat-e-Maweez | Iron-rich, liver tonic |
| Sharbat-e-Anar | Hematinic, digestive |
| Majoon Khabsul Hadeed | Iron supplement |
| Kushta Khabsul Hadeed | 125 mg/day - iron supplementation |
| Jawarish Amla | Digestive + liver tonic |
| Qurs Kushta Faulad | Iron supplement |
| Sharbat-e-Afsanteen | Liver + spleen tonic (hepatosplenomegaly mein) |
| Dawa-ul-Kurkum | Liver + spleen tonic |
2. LEUKEMIA - SARTAN-UD-DAM (سرطان الدم)
(Refer to previous detailed notes - covered in leukemia session)
Quick Modern Summary:
| Type | Key Feature | Treatment |
|---|
| ALL | Children, TdT+, t(9;22) BCR-ABL | Vincristine+Pred+MTX; CAR-T (tisagenlecleucel) |
| AML | Adults, >20% blasts, Auer rods | Cytarabine + Idarubicin; HSCT |
| CML | t(9;22) Philadelphia chromosome, BCR-ABL | Imatinib (TKI) |
| CLL | Elderly, smudge cells, CD5+CD19+ | Ibrutinib, Venetoclax |
Unani:
- Sartan-ud-Dam - excess/burnt Sauda causing leukemic proliferation
- Treatment: Musaffiyat-e-Khoon, Khamira Abresham, Muqawwiyat, supportive + modern referral
3. THALASSEMIA
MODERN MEDICINE
Definition
Genetic hemoglobinopathy - defective alpha or beta globin chain synthesis → microcytic hemolytic anemia
Types
Beta Thalassemia:
| Type | Globin Chains | Clinical Features |
|---|
| Thalassemia Minor (Trait) | One β gene defective | Mild/no anemia, carrier state |
| Thalassemia Intermedia | Two β genes, partial | Moderate anemia, splenomegaly |
| Thalassemia Major (Cooley's Anemia) | Both β genes defective | Severe transfusion-dependent anemia, starts 6-12 months of life |
Alpha Thalassemia:
| Type | Genes deleted | Clinical |
|---|
| Silent carrier | 1 gene | Normal |
| Alpha trait | 2 genes | Mild anemia |
| HbH disease | 3 genes | Moderate hemolytic anemia |
| Hydrops fetalis | 4 genes | Incompatible with life (stillbirth) |
Clinical Features (Thalassemia Major)
- Severe anemia from 6 months (when HbF → HbA switch happens)
- Hepatosplenomegaly (extramedullary hematopoiesis)
- Bone deformities - "Crew-cut" skull X-ray, frontal bossing, maxillary hypertrophy ("chipmunk face") - due to marrow expansion
- Growth retardation, delayed puberty
- Iron overload (from repeated transfusions): cardiomyopathy, liver cirrhosis, endocrinopathy
Diagnosis
- Hb Electrophoresis - gold standard
- Thalassemia Major: HbF ↑↑, HbA absent or ↓, HbA2 ↑
- Thalassemia Minor: HbA2 >3.5% (key finding)
- CBC: Microcytic hypochromic anemia, ↑ RBC count
- Blood film: Target cells, nucleated RBCs
Treatment
- Thalassemia Major:
- Regular blood transfusions (every 3-4 weeks) to maintain Hb >9-10 g/dL
- Iron chelation (Deferoxamine/Deferasirox) - to prevent iron overload
- Allogeneic HSCT (Bone Marrow Transplant) - only cure
- Hydroxyurea - increases HbF (fetal hemoglobin) production
- Gene therapy (emerging - betibeglogene)
- Thalassemia Minor: No treatment needed, genetic counseling
- Prevention: Premarital screening + Hb electrophoresis of both partners
UNANI - THALASSEMIA
Unani Concept: Thalassemia - Khoon ki Khilqati (congenital) kharaabi - Soo-ul-Mizaj-e-Mawlood (congenital temperamental disorder) + Zo'f-e-Ghizai (nutritive weakness)
Unani Pathogenesis:
- Ghair-Tabayee Takween-e-Khoon (abnormal blood formation)
- Za'f-e-Kabid (liver weakness) - since liver is the organ of blood formation in Unani theory
- Excess Safra mixing with khoon causing hemolysis
Unani Single Drugs for Thalassemia Support:
| Drug | Scientific Name | Action |
|---|
| Ashwagandha (Asgand) | Withania somnifera | Reduces impurities, blood tonic, immune |
| Hibiscus (Gule Gurhal) | Hibiscus rosa-sinensis | Blood purifier, anti-inflammatory |
| Amla | Emblica officinalis | Antioxidant, iron absorption aid |
| Zafran | Crocus sativus | Blood quality improver |
| Khabsul Hadeed | Ferric oxide | Iron supplement |
Compound Formulations: Khamira Abresham (antioxidant), Sharbat-e-Faulad, Dawa-ul-Kurkum
Note: Thalassemia major mein modern transfusion + chelation laazimi hai. Unani treatment supportive role mein hai (iron absorption, antioxidant support, immune boosting).
4. HEMOPHILIA - NAZF-UD-DAM MIZAJI (نزف الدم مزاجی)
MODERN MEDICINE
Definition
X-linked recessive bleeding disorder due to deficiency of clotting factor
| Type | Deficient Factor | Gene |
|---|
| Hemophilia A | Factor VIII | F8 gene (X-linked) |
| Hemophilia B (Christmas disease) | Factor IX | F9 gene (X-linked) |
- Affects males primarily; females are carriers (but can have mild disease)
Severity Classification
| Severity | Factor Level | Bleeding Pattern |
|---|
| Mild | 5-40% | Only with surgery/trauma |
| Moderate | 1-5% | With minor trauma |
| Severe | <1% | Spontaneous bleeding |
Clinical Features
- Hemarthrosis (bleeding into joints) - most characteristic; leads to chronic arthropathy
- Soft tissue hematomas, muscle bleeds
- Prolonged bleeding after cuts, surgery, dental procedures
- Intracranial hemorrhage (life-threatening)
- No petechiae/purpura (platelet function normal)
Investigations
| Test | Result in Hemophilia |
|---|
| aPTT | ↑ Prolonged |
| PT | Normal |
| Platelet count | Normal |
| Bleeding time | Normal |
| Specific factor assay | ↓ Factor VIII or IX |
Treatment
- Hemophilia A: Factor VIII concentrate (recombinant or plasma-derived)
- Prophylactic treatment to prevent joint damage
- Emicizumab (Hemlibra) - subcutaneous bispecific antibody mimicking Factor VIII
- Hemophilia B: Factor IX concentrate
- DDAVP (Desmopressin) - mild hemophilia A (releases stored Factor VIII)
- Avoid NSAIDs, aspirin (worsen bleeding)
- Gene therapy: Emerging - promising results in clinical trials
UNANI - NAZF-UD-DAM MIZAJI
Unani Definition:
- Nazf-ud-Dam = hemorrhage/bleeding
- Nazf-ud-Dam Mizaji = bleeding due to Soo-e-Mizaj (temperamental imbalance) - Harr (hot) mizaj causing vessels to be lax and blood to flow excessively
Unani Pathogenesis:
- Hararat-e-Harr (excess heat) → khoon patla aur zyada maayil (fluid) hota hai → vessels se bahar aata hai
- Zo'f-e-Mamsika (weakness of retentive faculty) → khoon ko rok nahi sakta
- Ghilzat-e-Dam not present → khoon bahut patla (thin)
Unani Treatment:
| Drug Type | Examples | Action |
|---|
| Qabizat (astringents) | Anar (pomegranate rind), Katha, Majuphal | Constrict vessels, stop bleeding |
| Mubarridat (coolants) | Sandal, Gule Nilofar, Nagarmotha | Reduce excess heat causing bleeding |
| Muqawwiyat-e-Uroq (vessel strengtheners) | Marjan (Coral), Moti (Pearl) | Strengthen vessel walls |
| Dawa-e-Haemostatic | Kushta Abresham, Lajward | Stop bleeding |
Compound Formulas:
- Qurs Hajar-ul-Yahud - urinary/general hemostasis
- Sharbat-e-Sandal - cooling, hemostatic
- Jawarish-e-Mastagi - astringent
Important: Hemophilia mein factor replacement modern medicine mein zaroori hai. Unani treatment supportive/adjunct role ada kar sakti hai - especially joint protection aur bleed prevention mein.
5. THROMBOCYTOPENIA - QILLAT-E-SUFEHIYAT-UD-DAM (قلة الصفيحات الدم)
MODERN MEDICINE
Definition
Platelet count < 150,000/µL (1.5 lac/µL)
Severity
| Grade | Platelet Count | Risk |
|---|
| Mild | 100,000-150,000 | Usually no bleeding |
| Moderate | 50,000-100,000 | Bleeding with trauma |
| Severe | 20,000-50,000 | Spontaneous bruising |
| Critical | <10,000-20,000 | Spontaneous life-threatening bleeding |
Classification & Causes
| Mechanism | Examples |
|---|
| ↓ Production | Aplastic anemia, leukemia, B12/folate deficiency, drugs (chemotherapy) |
| ↑ Destruction | ITP (immune), DIC, TTP, HUS, HIT (heparin-induced) |
| Sequestration | Hypersplenism (splenomegaly) |
ITP - Immune Thrombocytopenic Purpura (Key Topic)
Pathophysiology:
- Autoantibodies (usually IgG anti-GPIIb/IIIa) coat platelets → splenic macrophage destruction
- Both impaired production AND T-cell mediated destruction
Clinical: Petechiae, purpura, mucosal bleeding, no lymphadenopathy, no hepatosplenomegaly
Diagnosis of Exclusion - no other cause found
Treatment Indication:
- Platelets <10,000/µL (any patient)
- Platelets <30,000/µL (pregnancy - 2nd/3rd trimester)
- Active bleeding
Treatment:
- 1st line: Prednisolone (1 mg/kg/day) OR IV Immunoglobulin (IVIG)
- 2nd line: Splenectomy (removes main site of platelet destruction + antibody production)
- 3rd line: Rituximab (anti-CD20), Thrombopoietin receptor agonists (Romiplostim, Eltrombopag)
- Platelet transfusion: Only for life-threatening bleeding (quickly destroyed)
UNANI - QILLAT-E-SUFEHIYAT-UD-DAM
Unani Concept: Platelets (Sufehi-ud-Dam = blood plates/discs) ki kami
Pathogenesis:
- Zo'f-e-Kabid - liver mein thrombopoeisis mein kami
- Ghaleez Khilt destroying blood components
- Imtilaa-e-Tihal (splenic congestion) causing increased platelet sequestration - equivalent to hypersplenism
Unani Treatment:
| Drug | Action |
|---|
| Marjan (Coral) | Muqawwi-e-Dam (blood strengthener), hemostatic |
| Moti/Lulu (Pearl) | Muqawwi, hemostatic |
| Katha | Astringent, vessel tightening |
| Anar Pust (pomegranate rind) | Qabiz (astringent), hemostatic |
| Gule Surkh (rose petals) | Blood tonic |
| Kushta Abresham | Blood cell strengthening |
Compound: Qurs Zahar Mohra, Kushta Marjan formulations
6. SICKLE CELL DISEASE
MODERN MEDICINE
Definition
Autosomal recessive hemoglobinopathy - point mutation in β-globin gene: Glutamic acid → Valine at position 6 → HbS formation
Pathophysiology
- Deoxygenation → HbS polymerization → RBC sickling → crescent-shaped cells
- Sickling causes:
- Hemolysis (intravascular + extravascular)
- Vaso-occlusion (microvascular occlusion → ischemia/infarction)
Subtypes (by severity)
| Genotype | Severity |
|---|
| HbSS (Sickle cell anemia) | Most severe |
| HbSβ0 (Sickle-β0 thalassemia) | Severe |
| HbSC (Sickle-hemoglobin C) | Moderate |
| HbSβ+ (Sickle-β+ thalassemia) | Mild-Moderate |
| HbAS (Sickle trait) | Carrier - protected from malaria |
Clinical Features
Acute Crises:
- Vaso-occlusive crisis (pain crisis) - most common; bones, chest, abdomen
- Acute Chest Syndrome - fever + chest pain + new infiltrate on X-ray (most common cause of death)
- Aplastic crisis - Parvovirus B19 infection → ↓ reticulocytes
- Sequestration crisis - sudden massive spleen/liver sequestration of RBCs → acute anemia
Chronic Complications:
- Autosplenectomy (by age 5 → susceptible to encapsulated organisms: Pneumococcus, Haemophilus, Meningococcus)
- Stroke (children - TCD >200 cm/sec = high risk)
- Avascular necrosis of femoral/humeral head
- Chronic organ damage: kidney (renal papillary necrosis), heart, lung
- Priapism (painful prolonged erection)
Diagnosis
- Newborn screening: Hb Electrophoresis
- Sickledex / Sickle prep: rapid screening (but misses variants)
- Blood film: Sickle-shaped cells, target cells, Howell-Jolly bodies
Treatment
| Drug/Intervention | Indication |
|---|
| Hydroxyurea | ↑ HbF → reduces sickling - mainstay of therapy |
| Analgesics (NSAIDs, opioids) | Pain crisis |
| IV fluids + O2 | Pain crisis, ACS |
| RBC exchange transfusion | Stroke, severe ACS, multiorgan failure |
| Allogeneic HSCT | Only cure (limited by donor availability) |
| Gene therapy (Lovo-cel) | FDA approved 2023 for adults |
| Vaccines | Pneumococcal, Haemophilus, Meningococcal (due to autosplenectomy) |
| Penicillin prophylaxis | Children <5 years |
| Crizanlizumab (anti-P-selectin) | Reduces vaso-occlusive crises |
| Voxelotor | Binds α-globin, reduces sickling |
UNANI - SICKLE CELL DISEASE
Unani Concept: Sickle cell = Khilqati Fasad-ud-Dam (congenital blood corruption) with Soo-e-Mizaj-e-Mawlood (hereditary temperament disorder)
- The "sickling" = Unani mein Ghilzat-e-Dam (thick/stiff blood) causing vascular obstruction (Sudad-e-Awridah)
- Vaso-occlusive crisis = Waja-ud-Dam (blood pain) due to blockage
Unani Approach:
| Aspect | Unani Treatment |
|---|
| Blood quality | Musaffiyat-e-Khoon (blood purifiers): Amla, Neem, Haldi |
| Anti-sickling | Asgand (Withania somnifera) - antioxidant, reduces RBC rigidity |
| Vascular | Muhallilat (resolvent drugs) - reduce vascular obstruction |
| Pain management | Musakkinat (analgesic herbs): Ajwain, Adrak, Zanjabeel |
| Liver support | Muqawwiyat-e-Kabid: Dawa-ul-Kurkum, Sharbat-e-Afsanteen |
| Spleen | Muqawwiyat-e-Tihal - spleen strengtheners |
Modern treatment essential. Hydroxyurea + gene therapy = current standard. Unani plays supportive role.
7. LYMPHOMA
MODERN MEDICINE
Classification
Two Main Types:
| Feature | Hodgkin Lymphoma (HL) | Non-Hodgkin Lymphoma (NHL) |
|---|
| Hallmark cell | Reed-Sternberg cell (owl-eye nuclei) | Absent |
| Spread | Contiguous (orderly) | Non-contiguous |
| Extranodal involvement | Rare | Common |
| Mediastinal mass | Common | Less common |
| Age | Bimodal (15-35 + >50) | Older adults mostly |
| Cure rate | Higher (>80% early stage) | Variable |
Hodgkin Lymphoma - Subtypes
| Subtype | Frequency | Features |
|---|
| Nodular Sclerosis | 65-70% | Most common; young women; mediastinal |
| Mixed Cellularity | 20-25% | EBV associated |
| Lymphocyte Rich | <5% | Best prognosis |
| Lymphocyte Depleted | <1% | Worst prognosis |
| NLPHL | 5% | CD20+ RS cells |
Staging (Ann Arbor / Lugano Classification)
| Stage | Definition |
|---|
| I | Single lymph node region |
| II | 2+ regions, same side of diaphragm |
| III | Both sides of diaphragm |
| IV | Extranodal involvement (liver, bone marrow, lung) |
- A = No B symptoms | B = Fever >38°C, night sweats, weight loss >10% in 6 months
Investigations
- CBC, LDH (prognostic marker), ESR
- CT scan chest/abdomen/pelvis
- PET-CT - gold standard for staging + response assessment
- Bone marrow biopsy (if stage IV suspected)
- Excision biopsy of lymph node - definitive diagnosis
Treatment
Hodgkin Lymphoma:
- ABVD chemotherapy (Adriamycin/Doxorubicin, Bleomycin, Vinblastine, Dacarbazine) - standard
- Radiotherapy for localized disease
- Advanced: BEACOPP, BV-AVD (brentuximab vedotin based)
Non-Hodgkin Lymphoma:
- DLBCL (aggressive): R-CHOP (Rituximab + Cyclophosphamide + Doxorubicin + Vincristine + Prednisolone)
- Follicular (indolent): Watch-and-wait or Rituximab + chemo
- CAR-T cell therapy: Relapsed/refractory DLBCL
UNANI - LYMPHOMA (WARM-E-GHUDAD)
Unani Concept:
- Warm-e-Ghudad (ورم الغدد) = lymph node swelling/malignancy
- Sartan-e-Ghudad = lymphoid cancer
- Caused by excess Sauda (black bile) accumulation in lymph nodes + Imtilaa-e-Ghudad
Unani Classification:
- Warm-e-Ghudad Saudawi - malignant lymphoma (hard, fixed, painless nodes)
- Warm-e-Ghudad Balghami - reactive lymphadenopathy (soft, painful)
Unani Treatment:
| Drug Type | Examples | Action |
|---|
| Muhallimat | Anjeer, Zarambad | Resolvent - reduce swelling |
| Munzijat-e-Sauda | Afsanteen, Rewand | Ripen + eliminate saudawi matter |
| Musaffiyat-e-Khoon | Chirayta, Neem, Bakayan | Blood purification |
| Muqawwiyat | Khamira Abresham, Mufarreh Yaqoot | General strength |
SUMMARY TABLE - NCISM Amraz-e-Dam
| Disease | Unani Name | Modern Key Point | Unani Key Drug |
|---|
| Anemia (Iron def.) | Soo-ul-Qiniya / Faqr-ud-Dam | Ferritin most sensitive test; Ferrous sulfate | Sharbat-e-Faulad, Kushta Khabsul Hadeed |
| Megaloblastic anemia | Faqr-ud-Dam Ghizai | Hypersegmented neutrophils; B12/Folate | Maweez, Zafran |
| Aplastic anemia | Fasad-e-Nakhaa (bone marrow fasad) | Pancytopenia; HSCT = cure | Khamira Abresham |
| Leukemia | Sartan-ud-Dam | >20% blasts; TKI for CML; CAR-T for ALL | Musaffiyat-e-Khoon |
| Thalassemia | Soo-ul-Mizaj Khilqati | Hb Electrophoresis; HbA2 ↑ | Asgand, Gule Gurhal |
| Hemophilia | Nazf-ud-Dam Mizaji | ↑ aPTT; normal PT; Factor VIII/IX low | Qabizat, Marjan |
| Thrombocytopenia | Qillat-e-Sufehiyat-ud-Dam | Platelets <150K; ITP = steroid/IVIG | Marjan, Moti, Katha |
| Sickle Cell | Fasad-e-Dam Khilqati | HbS - Glu→Val; Hydroxyurea | Asgand, Musaffiyat |
| Lymphoma | Sartan-e-Ghudad / Warm-e-Ghudad | Reed-Sternberg cell; ABVD chemo | Munzijat-e-Sauda, Chirayta |
Exam Tip (NCISM BUMS): Har disease mein Asbaab (Causes), Alamaat (Symptoms), Tashkhees (Diagnosis), Usool-e-Ilaj (Treatment Principles), aur Ilaj (Treatment) - Modern + Unani dono likhen. Key Unani terms yaad rakhein: Soo-ul-Qiniya, Faqr-ud-Dam, Zo'f-e-Kabid, Musaffiyat-e-Khoon, Mowallid-e-Dam.
- Katzung's Basic and Clinical Pharmacology, 16th Ed.
- Quick Compendium of Clinical Pathology, 5th Ed.
- Harriet Lane Handbook, 23rd Ed.
- Soo-ul-Qiniya - IJUIM Journal
- NCISM BUMS Syllabus - Amraz-e-Dam